Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 15, 2010
Patent Application Number
10118473
Date Filed
April 5, 2002
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides methods of use of various antibody-immunostimulant fusion proteins as adjuvants of antigenic protein vaccinations to elicit humoral and/or cellular immune responses in vaccinated subjects. Compositions which include these fusion proteins and innate and/or exogenous antigenic proteins are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
